PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

Journals
More Content
PLOS BLOGS Speaking of Medicine and Health
Browse all PLOS Blogs
Browse all PLOS Blogs

This Week in PLoS Medicine: HAART and HIV in DR Congo; blood pressure in the UK; the health risks to migrants of ‘interception strategies’

PLOS General

Two Research Articles, a Policy Forum, and the fifth installment of our Migration and Health series were published in this week’s PLoS Medicine.

Image Credit: topgold

An observational study by Andrew Edmonds and colleagues reports that treatment with highly active antiretroviral therapy (HAART) markedly improves the survival of HIV-infected children in Kinshasa, DRC, a resource-poor setting. Andrew Wills and colleagues analyze eight population-based and occupational cohorts from the UK, revealing the patterns of change in blood pressure through the life course of these populations.

A quick, easy, valid, and precise method of estimating HIV incidence in populations is needed, say Timothy Hallett and colleagues in a Policy Forum. And in the fifth article in our Migration and Health series Zachary Steel and colleagues discuss the health risks associated with “interception strategies” that are used by governments to control and order international migration, especially in terms of halting the movement of irregular migrants, including asylum seekers.

Back to top